Le Lézard
Classified in: Covid-19 virus

The Worldwide Metal Nanoparticle Industry is Expected to Reach $81.5 Billion by 2028 - ResearchAndMarkets.com


The "Global Metal Nanoparticle Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Metal (Platinum, Gold, Silver, Iron, Titanium, and Others) and End-Use Industry" report has been added to ResearchAndMarkets.com's offering.

The global metal nanoparticles market was valued at US$ 25,373.92 million in 2020 and is projected to reach US$ 81,567.38 million by 2028; it is expected to grow at a CAGR of 15.9% from 2021 to 2028.

Metal Nanoparticles have exceptional properties such as high aspect ratio and uniform size. They are used in a wide spectrum of applications, such as catalysis, medical, and energy storage. The metal nanoparticles have various applications in end-use industries, such as pharmaceuticals and healthcare, chemical, cosmetics, and electrical and electronics.

Based on end-use industry, the global metal nanoparticles market is segmented into pharmaceutical and healthcare, electrical and electronics, chemicals, personal care and cosmetics, and others. The pharmaceuticals and healthcare segment held the largest market share in 2020. Metal nanoparticles have various applications in the pharmaceutical and healthcare sector such as their use as therapeutic agents as well as in drug delivery, bioimaging, and cancer treatment and diagnostics. Many countries across the world are researching on metal nanoparticles that can be applied for cancer treatment. Along with this, the use of gold nanoparticles in the COVID-19 antibodies test kits is driving the demand for metal nanoparticles in the pharmaceutical and healthcare sector.

Geographically, the metal nanoparticles market is segmented into North America, Europe, Asia Pacific (APAC), South America (SAM), and Middle East & Africa (MEA). In 2020, North America dominated the market. The increased applications of metal nanoparticles in industries, such as healthcare, cosmetic, and electricals and electronics, and the presence of domestic and international companies operating in the region and continuously enhancing the overall business processes would create lucrative growth opportunities for the market in North America during the forecast period. Along with this, an increased use of gold nanoparticles in the development of photovoltaic or solar cell is driving the metal nanoparticles market growth in the region.

The ongoing COVID-19 pandemic has had a significant impact on the metal nanoparticles market. The outbreak has distorted operational efficiency and disrupted the value chains due to the sudden shutdown of national and international boundaries, which has created revenue loss and damage. The disruptions in the production and supply chain have had a negative impact on the metal nanoparticles market. The implementation of lockdown in various countries along with travel restrictions has lessened the global supply of products along with a reduced logistic operation.

Research has been ongoing for the utilization of gold nanoparticles for COVID-19 testing kits, which will provide the results in minutes. In the US, a group of researchers at the University of Maryland claimed that they have developed a diagnostic test that can detect the novel coronavirus that causes COVID-19 within 10 minutes and the results will be visible with naked eyes. The test is a simple colorimetry-based assay, which uses gold nanoparticles that are capped with the nucleic acid sequence of the nucleocapsid phosphoprotein of the SARS-COV-2 virus.

Reasons to buy

Market Dynamics

Drivers

Restraints

Opportunities

Future Trends

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/9dhf40


These press releases may also interest you

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

24 avr 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

24 avr 2024
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

24 avr 2024
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...



News published on and distributed by: